Generic Name

Clarithromycin

FDA approval date: August 25, 2005
Classification: Macrolide Antimicrobial
Form: Tablet, For

What is Clarithromycin?

Clarithromycin is a macrolide antimicrobial indicated for mild to moderate infections caused by designated, susceptible bacteria in the following: Acute Bacterial Exacerbation of Chronic Bronchitis in Adults.

Approved To Treat

Top Global Experts

There are no experts for this drug

Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms

Related Clinical Trials

There is no clinical trials being done for this treatment

Related Latest Advances

Evaluation of mlstverse system for accurate subspecies identification and drug resistance prediction in Mycobacterium abscessus species.
Evaluation of mlstverse system for accurate subspecies identification and drug resistance prediction in Mycobacterium abscessus species.
Journal: Microbiology spectrum
Published: July 31, 2025
Reassessment of extracellular and intracellular activity of macrolides, rifampicin, and doxycycline against Rhodococcus equi based on bacterial counts and microscopy.
Reassessment of extracellular and intracellular activity of macrolides, rifampicin, and doxycycline against Rhodococcus equi based on bacterial counts and microscopy.
Journal: Microbiology spectrum
Published: July 29, 2025
Comparison of bismuth and concomitant therapy for H. pylori eradication: a prospective, randomized clinical trial.
Comparison of bismuth and concomitant therapy for H. pylori eradication: a prospective, randomized clinical trial.
Journal: Future science OA
Published: July 10, 2025
View All Latest Advances